Bill Search

  • Introduced
    Jan 23, 2025
  • Passed Senate
    Apr 10, 2025
  • Passed House
  • Signed into Law
SB 883
Texas Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Last Action See all actions
House • Apr 14, 2025: Received from the Senate
Latest Bill Text See all bill texts

Summary/Bill Text

Comments on SB 883

Tweets

Whip Lists

Sponsors
Actions
  • Apr 14, 2025 | House
    • Received from the Senate
  • Apr 10, 2025 | Senate
    • Co-author authorized
    • Rules suspended-Regular order of business
    • Record vote
    • Read 2nd time & passed to engrossment
    • Record vote
    • Rules suspended-Regular order of business
    • Record vote
    • Read 3rd time
    • Passed
    • Record vote
    • Reported engrossed
  • Apr 09, 2025 | Senate
    • Placed on intent calendar
  • Apr 07, 2025 | Senate
    • Reported favorably w/o amendments
    • Committee report printed and distributed
  • Apr 02, 2025 | Senate
    • Considered in public hearing
    • Vote taken in committee
  • Apr 01, 2025 | Senate
    • Scheduled for public hearing on . . . 04/01/2025
    • Considered in public hearing
    • Testimony taken in committee
    • Left pending in committee
  • Mar 20, 2025 | Senate
    • Co-author authorized
  • Feb 13, 2025 | Senate
    • Read first time
    • Referred to Health & Human Services
  • Jan 23, 2025 | Senate
    • Received by the Secretary of the Senate
    • Filed